Fields »
ABOUT
HELP
BLOG

475 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 10 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
HMMRHyaluronan-mediated motility receptor (RHAMM)CD markers
FDA approved drug targets
Predicted intracellular proteins
Microtubules
Centrosome
Cytosol		Tissue enhanced
HPD4-hydroxyphenylpyruvate dioxygenaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nuclear specklesGroup enriched
HPRT1Hypoxanthine phosphoribosyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolExpressed in all
HRH1Histamine receptor H1FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cytosol		Mixed
HRH2Histamine receptor H2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HSD3B1Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
HSD3B2Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
HTR1A5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupledDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
HTR1B5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
HTR1F5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HTR2A5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR2B5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
NucleoplasmTissue enhanced
HTR45-hydroxytryptamine (serotonin) receptor 4, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR75-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins
Nuclear speckles
Plasma membrane
Cytosol		Group enriched
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol		Expressed in all
IDEInsulin-degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
IFNGInterferon, gammaCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IKBKBInhibitor of kappa light polypeptide gene enhancer in B-cells, kinase betaCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
CytosolMixed
IMPDH1IMP (inosine 5'-monophosphate) dehydrogenase 1Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Cytosol
Rods & Rings		Expressed in all
IMPDH2IMP (inosine 5'-monophosphate) dehydrogenase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Cytosol
Rods & Rings		Expressed in all
ITGA2BIntegrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)Cancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cell Junctions
Cytosol		Tissue enhanced
ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
JAK1Janus kinase 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
JAK2Janus kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Focal adhesion sites		Mixed
JAK3Janus kinase 3Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
CytosolTissue enhanced
JUNJun proto-oncogeneCancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Transcription factors
NucleoplasmExpressed in all
KCNA1Potassium channel, voltage gated shaker related subfamily A, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium channel, voltage gated shaker related subfamily A, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Cytosol		Tissue enhanced
KCNA2Potassium channel, voltage gated shaker related subfamily A, member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium channel, voltage gated shaker related subfamily A, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium channel, voltage gated shaker related subfamily A, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium channel, voltage gated shaker related subfamily A, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNA6Potassium voltage-gated channel subfamily A member 6 FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNB1Potassium channel, voltage gated Shab related subfamily B, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium channel, voltage gated Shab related subfamily B, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Plasma membrane
Midbody		Tissue enhanced
KCNC1Potassium channel, voltage gated Shaw related subfamily C, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleus
Nuclear membrane
Vesicles
Cytosol		Tissue enriched
KCNC2Potassium channel, voltage gated Shaw related subfamily C, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Cytosol		Tissue enriched
KCNC3Potassium channel, voltage gated Shaw related subfamily C, member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND1Potassium channel, voltage gated Shal related subfamily D, member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
NucleusMixed
KCND2Potassium channel, voltage gated Shal related subfamily D, member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium channel, voltage gated Shal related subfamily D, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNJ1Potassium channel, inwardly rectifying subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium channel, inwardly rectifying subfamily J, member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium channel, inwardly rectifying subfamily J, member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Cytosol		Group enriched
KCNJ8Potassium channel, inwardly rectifying subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK2Potassium channel, two pore domain subfamily K, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Mitochondria
Cytosol		Tissue enhanced
KCNMA1Potassium channel, calcium activated large conductance subfamily M alpha, member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium channel, voltage gated KQT-like subfamily Q, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced

« prev | Page of 10 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.